Article info
PDFRheumatoid arthritis
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis
- Correspondence to Dr Alexandre Sepriano, Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands; alexsepriano{at}gmail.com
Citation
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis
Publication history
- Received November 16, 2019
- Revised December 23, 2019
- Accepted December 27, 2019
- First published February 7, 2020.
Online issue publication
May 20, 2020
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.